Breast Cancer
Feature
Last call? Moderate alcohol’s health benefits look increasingly doubtful
These new findings mean physicians will find themselves imparting a more nuanced message about the health impacts of moderate alcohol consumption...
From the Journals
Bariatric surgery can lead to diabetes remission, cut cancer risk
Patients with obesity and type 2 diabetes who underwent bariatric surgery have a lower cancer risk. “Obesity may cause more cancer cases than...
Feature
Axilla swelling after COVID booster puts focus on mammogram timing
Experts and imaging center staff give recommendations regarding the timing of getting boosters and mammograms.
Latest News
Postmenopausal women with early breast cancer can go chemo-free
“This will save tens of thousands of women the time, expense, and potentially harmful side effects that can be associated with chemotherapy...
Conference Coverage
Cardiovascular effects of breast cancer treatment vary based on weight, menopausal status
The risk of dyslipidemia was higher in postmenopausal aromatase inhibitors users and lower in postmenopausal tamoxifen users, compared with...
Conference Coverage
Cancer risk tied to some manufactured foods
The results of three European studies support the removal of trans fatty acids, nitrites, and nitrates from food products.
Conference Coverage
Breast cancer-related musculoskeletal pain alleviated with acupuncture
A new study shows that electroacupuncture and auricular acupuncture may relieve debilitating chronic musculoskeletal pain for breast cancer...
Latest News
More evidence ties some antipsychotics to increased breast cancer risk
The relative risk for breast cancer was 62% higher in women who took category 1 antipsychotic medications associated with high prolactin levels....
Conference Coverage
Sacituzumab govitecan effective in Black mTNBC patients
Black women may have outcomes comparable to those of other women when given sacituzumab govitecan for the treatment of metastatic TNBC, suggests...
Conference Coverage
PD-L1 cutoff for pembrolizumab in mTNBC confirmed
PD-L1 CPS of at least 10 improves overall survival by 28%-29%. Further analysis of responses to pembrolizumab plus chemotherapy in metastatic TNBC...
Latest News
Pembrolizumab improves event-free survival in early TNBC
Neoadjuvant pembrolizumab benefits early TNBC patients regardless of disease stage and nodal status. Event-free survival improved by about 35%...